News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Strand Life Sciences And Pharmidex To Collaborate To Produce A New In Silico Technology For CNS Drug Discovery
February 21, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Strand Life Sciences, the premier in silico technologies innovation company announced today that it has entered into collaboration with Pharmidex, a world leader in assessing the ability of compounds to cross the blood-brain barrier (BBB).
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
MORE ON THIS TOPIC
Layoff Tracker
Intercept Fires 146 After Pulling Liver Disease Drug
December 18, 2025
·
97 min read
·
BioSpace Editorial Staff
Layoffs
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs
December 18, 2025
·
2 min read
·
Tristan Manalac
China
BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour
December 17, 2025
·
1 min read
·
Tristan Manalac
Artificial intelligence
Roche Makes Good on Dealmaking Promise With $1.1B Caris Cancer Collab
December 17, 2025
·
1 min read
·
Tristan Manalac